vx-745 has been researched along with Astrocytoma, Grade IV in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chen, JY; Su, BC | 1 |
Bell-Pedersen, D; Earnest, DJ; Goldsmith, CS; Karunarathna, N; Kim, SM; Neuendorff, N; Toussaint, LG | 1 |
2 other study(ies) available for vx-745 and Astrocytoma, Grade IV
Article | Year |
---|---|
Pharmacological inhibition of p38 potentiates antimicrobial peptide TP4-induced cell death in glioblastoma cells.
Topics: Animals; Antimicrobial Cationic Peptides; Cell Death; Cell Line, Tumor; Female; Glioblastoma; Humans; Imidazoles; Neoplasm Proteins; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Pyridazines; Pyridines; Pyrimidines; Thymopoietins; Tilapia; Triple Negative Breast Neoplasms | 2020 |
Inhibition of p38 MAPK activity leads to cell type-specific effects on the molecular circadian clock and time-dependent reduction of glioma cell invasiveness.
Topics: Animals; Cell Lineage; Circadian Clocks; CLOCK Proteins; Fibroblasts; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Luciferases; Mice; Neoplasm Invasiveness; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridazines; Pyrimidines; Signal Transduction | 2018 |